4-(1-(4-(2-aminoethoxy)phenyl)-4-chloro-2-phenylbut-1-en-1-yl)phenol

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4-(1-(4-(2-aminoethoxy)phenyl)-4-chloro-2-phenylbut-1-en-1-yl)phenol
• 英文别名: 4-[1-[4-(2-Aminoethoxy)phenyl]-4-chloro-2-phenylbut-1-enyl]phenol；4-[1-[4-(2-aminoethoxy)phenyl]-4-chloro-2-phenylbut-1-enyl]phenol
• 化学式: C₂₄H₂₄ClNO₂
• 分子量: 393.913
• InChiKey: SFJFIRAZZLSDLG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  28
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  55.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4,4'-二羟基二苯甲酮 在 lithium aluminium tetrahydride 、 四氯化钛 、 potassium carbonate 、 锌 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 6.5h， 生成 4-(1-(4-(2-aminoethoxy)phenyl)-4-chloro-2-phenylbut-1-en-1-yl)phenol
  参考文献：
  名称：

  ER PROTEIN REGULATORS AND USE THEREOF

  摘要：

  本公开涉及一种由式(I)表示的ER蛋白质调节剂化合物及其使用。式(I)中的LIN是连接剂；ULM是VHL或CRBN蛋白酶的小分子配体，具有泛素化功能；X基团为CH2、O或NH，X基团通过连接剂LIN与ULM共价连接。本公开设计和合成的化合物具有广泛的药理活性，具有调节ER蛋白质和抑制肿瘤活性的功能，并可用于预防和/或治疗与雌激素受体相关的疾病和紊乱，或相关肿瘤治疗。

  公开号：

  US20220016102A1

文献信息

• ER PROTEIN REGULATORS AND USE THEREOF
  申请人：ShanghaiTech University

  公开号：US20220016102A1

  公开（公告）日：2022-01-20

  The present disclosure relates to an ER protein regulator compound represented by formula (I) and use thereof. LIN in the compound represented by formula (I) is a linker; ULM is a small-molecule ligand of VHL or CRBN protease having a ubiquitylation function; and group X is CH 2 , O or NH, and group X is covalently linked to ULM by means of the linker LIN. The designed and synthesized compounds of the present disclosure have wide pharmacological activity, has the function of regulating ER protein and inhibiting the activity of tumors, and can be used for preventing and/or treating diseases and disorders associated with estrogen receptors, or related tumor treatment.

  本公开涉及一种由式(I)表示的ER蛋白质调节剂化合物及其使用。式(I)中的LIN是连接剂；ULM是VHL或CRBN蛋白酶的小分子配体，具有泛素化功能；X基团为CH2、O或NH，X基团通过连接剂LIN与ULM共价连接。本公开设计和合成的化合物具有广泛的药理活性，具有调节ER蛋白质和抑制肿瘤活性的功能，并可用于预防和/或治疗与雌激素受体相关的疾病和紊乱，或相关肿瘤治疗。
• EP3778590
  申请人：——

  公开号：——

  公开（公告）日：——
• Design and Synthesis of Norendoxifen Analogues with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities
  作者：Wei Lv、Jinzhong Liu、Todd C. Skaar、David A. Flockhart、Mark Cushman

  DOI：10.1021/jm501218e

  日期：2015.3.26

  Both selective estrogen receptor modulators and aromatase inhibitors are widely used for the treatment of breast cancer. Compounds with both aromatase inhibitory and estrogen receptor modulatory activities could have special advantages for treatment of breast cancer. Our previous efforts led to the discovery of norendoxifen as the first compound with dual aromatase inhibitory and estrogen receptor binding activities. To optimize its efficacy and aromatase selectivity versus other cytochrome P450 enzyme, a series of structurally related norendoxifen analogues were designed and synthesized. The most potent compound, 4'-hydroxynorendoxifen (10), displayed elevated inhibitory potency against aromatase and enhanced affinity for estrogen receptors when compared to norendoxifen. The selectivity of 10 for aromatase versus other cytochrome P450 eniymes was also superior to norendoxifen. 4'-Hydroxynorendoxifen is therefore an interesting lead for further development to obtain new anticancer agents of potential value for the treatment of breast cancer.